Clinical data
| Patient | Sex | Age (years) | Diagnosis | History |
1-150Systolic gradient (mm Hg) | Drugs influencing heart action |
|---|---|---|---|---|---|---|
| 1 | M | 26 | HCMP | – | < 10 | Metoprolol |
| 2 | M | 23 | HCMP | – | < 10 | Metoprolol |
| 3 | F | 30 | HCMP | – | < 10 | Sotalol, verapamil |
| 4 | M | 52 | HCMP | – | < 10 | Sotalol, lisinopril |
| 5 | F | 42 | HT | – | < 10 | Atenolol, nifedipine, lisinopril |
| 6 | M | 63 | HT | A | < 10 | Felodipine, metoprolol |
| 7 | M | 51 | HT | A, U | < 10 | Amlodipine, doxazosine |
| 8 | M | 58 | HT | – | < 10 | – |
| 9 | F | 47 | HCMP | – | 61 | Metoprolol, diltiazem |
| 10 | F | 63 | HT | D | < 10 | Metoprolol |
| 11 | M | 72 | HT | A | 13 | Enalapril, flecainide, digoxin |
| 12 | M | 67 | HT | A | < 10 | Captopril, atenolol |
| 13 | F | 51 | HT | A | < 10 | Doxazosin, diltiazem, atenolol |
| 14 | F | 43 | HCMP | – | < 10 | Sotalol |
| 15 | F | 46 | HCMP | – | 11 | Atenolol |
| 16 | M | 48 | HT | – | < 10 | Atenolol, lisonipril |
↵1-150 Subvalvar maximum, by Doppler.
A, angina pectoris; D, diabetes; U, uraemia, HCMP, hypertrophic cardiomyopathy; HT, hypertension.